Results 281 to 290 of about 1,367,522 (352)

Health evidence meets politics: informing the development and evaluation of electoral platforms in Lebanon. [PDF]

Health Res Policy Syst
El-Jardali F, Bou-Karroum L, Salameh S, Fadlallah R, Charif R, Assal M.   +5 more
europepmc   +1 more source

“You're this person who's providing light”: Embodied responses to information loss and transition within LGBTQIA+ communities

Journal of the Association for Information Science and Technology, EarlyView.
Abstract This paper reports on findings from 15 semi‐structured interviews with LGBTQIA+ individuals within the United States who have experienced the loss of one or more LGBTQIA+ information spaces. The paper specifically focuses on how such losses occurred and the information transitions experienced by the participants in response to this loss ...
Travis L. Wagner, Vanessa L. Kitzie
wiley   +1 more source

Willingness, preference, and resistance to frailty intervention for older gastric cancer based on stakeholder perspective: a qualitative study. [PDF]

BMC Geriatr
Guo Y, Song S, Ding L, Duan L, Zhu H, Zhao K, Xu T, Chen L, Hou H, Xu X, Xu Q.   +10 more
europepmc   +1 more source

From cramming to binge‐watching: Integrating documentary‐based assessment into a pharmacology and toxicology curriculum—a qualitative study

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims In the context of pharmacology and toxicology education, there is a growing shift toward programmatic assessment models that prioritize longitudinal learning, reflection and development of higher‐order cognitive skills. As part of this transition, we are exploring alternative and more meaningful forms of assessment. This qualitative study
Narin Akrawi, Heleen van der Sijs, Floor van Rosse   +2 more
wiley   +1 more source

Applying the advocacy coalition framework to wildlife management: Explaining policy change for damage mitigation in Japan. [PDF]

PLoS One
Koga T.
europepmc   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Restoring institutional confidence in backsliding democracies: Evidence from Mexico. [PDF]

Proc Natl Acad Sci U S A
Bessen B, Stokes S, Uribe A.
europepmc   +1 more source

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

The Spanish Political Attitudes Panel (12 waves). [PDF]

Sci Data
Pannico R, Galais C, Hernández E, Rico G, Anduiza E.   +4 more
europepmc   +1 more source